Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
002793 Luoxin Pharmaceuticals Group Stock
- 4.72
- +0.43+10.02%
Not Open Apr 24 15:00 CST
5.13BMarket Cap-5.56P/E (TTM)
4.72High4.30Low584.46KlotVolume4.30Open4.29Pre Close270.46MTurnover5.38%Turnover RatioLossP/E (Static)1.09BShares5.3252wk High3.68P/B5.13BFloat Cap3.2252wk Low4.72Limit Up1.09BShs Float27.94Historical High3.86Limit Down9.79%Amplitude3.22Historical Low--Dividend TTM4.63Avg Price285.88KlotAsk--Div YieldTTM100Lot Size283.76KlotBid
Luoxin Pharmaceuticals Group Stock Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -1.68%645.62M | -8.55%2.41B | -8.50%1.78B | -6.34%1.22B | -1.42%656.67M | -28.22%2.63B | -45.07%1.94B | -46.75%1.3B | -34.28%666.16M | -41.59%3.67B |
| Refunds of taxes and levies | -93.07%388.17K | -93.13%11.87M | -92.07%9.16M | -93.17%6.5M | --5.6M | 3,586.26%172.79M | --115.48M | --95.11M | ---- | -71.35%4.69M |
| Cash received relating to other operating activities | 28.56%23.56M | 3.31%83.42M | -40.95%77.8M | -34.39%61.9M | -71.90%18.33M | -88.43%80.75M | -54.68%131.74M | -70.58%94.35M | -74.94%65.21M | 241.56%697.82M |
| Cash inflows from operating activities | -1.62%669.57M | -13.28%2.5B | -14.85%1.87B | -13.67%1.28B | -6.94%680.6M | -33.95%2.89B | -42.79%2.19B | -46.08%1.49B | -42.59%731.37M | -32.77%4.37B |
| Goods services cash paid | -59.62%94.51M | -3.50%809.62M | 5.77%544.23M | 20.64%384.46M | -1.29%234.07M | -52.81%839.01M | -78.24%514.55M | -81.98%318.69M | -75.16%237.14M | -34.14%1.78B |
| Staff behalf paid | -3.95%154.61M | -6.80%637.74M | -5.61%472.35M | -10.39%333.4M | 3.75%160.97M | -25.64%684.27M | -22.67%500.41M | -17.84%372.03M | -21.43%155.14M | 24.90%920.17M |
| All taxes paid | 10.67%49.82M | -30.89%113.91M | -35.62%90.85M | -17.95%77.04M | 7.69%45.02M | -71.87%164.84M | -66.46%141.13M | -70.35%93.89M | -80.27%41.8M | -11.53%585.9M |
| Cash paid relating to other operating activities | -36.41%214.05M | 50.29%1.1B | 28.17%921.29M | 11.30%634.49M | 24.48%336.63M | -63.88%731.99M | -53.27%718.77M | -46.41%570.09M | -61.58%270.44M | -11.21%2.03B |
| Cash outflows from operating activities | -33.95%512.99M | 9.97%2.66B | 8.21%2.03B | 5.51%1.43B | 10.24%776.68M | -54.43%2.42B | -62.28%1.87B | -62.39%1.35B | -65.93%704.52M | -16.78%5.31B |
| Net cash flows from operating activities | 262.96%156.58M | -133.81%-157.85M | -151.26%-162.46M | -209.30%-145.2M | -457.83%-96.08M | 149.72%466.89M | 127.82%316.95M | 115.76%132.84M | 103.38%26.85M | -878.50%-939.13M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | -70.52%10.9M | -76.51%8.8M | -67.95%8.8M | -98.92%6.75M | -74.01%36.97M | -68.31%37.46M | -49.00%27.46M | 1,653.24%627.66M | 153.33%142.28M |
| Cash received from returns on investments | ---- | -99.91%73.03K | -99.98%15.36K | -99.98%15.36K | -79.64%11.92K | 2,158.53%85.9M | 7,240.91%86.51M | 22,539.29%85.09M | -33.13%58.52K | 954.09%3.8M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --188.68K | -22.37%5.32M | -21.38%2.69M | -31.86%2.31M | ---- | 123.04%6.85M | 558.07%3.42M | 616.92%3.39M | -54.68%214.07K | 44.03%3.07M |
| Net cash received from disposal of subsidiaries and other business units | -80.75%3.75M | --101.65M | --101.65M | --98.97M | --19.5M | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | --450K | -99.83%1.87M | -99.83%1.87M | ---- | ---- | 1,522.91%1.09B | 1,907.88%1.1B | 1,884.19%824.43M | -62.54%2.48M | 54.46%67.42M |
| Cash inflows from investing activities | -83.28%4.39M | -90.21%119.82M | -90.60%115.03M | -88.29%110.1M | -95.83%26.26M | 465.10%1.22B | 601.13%1.22B | 877.13%940.37M | 1,367.10%630.41M | 111.69%216.57M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -54.11%6.11M | -52.41%115.35M | -43.22%90.86M | -6.56%63.53M | -67.88%13.31M | 24.42%242.39M | -33.24%160.02M | -54.46%67.99M | -67.81%41.45M | -36.96%194.82M |
| Cash paid to acquire investments | 6.67%4M | -75.83%5.8M | -72.38%5.8M | -51.67%5.8M | -6.25%3.75M | -68.80%24M | -53.34%21M | -43.15%12M | -50.69%4M | -44.14%76.93M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -57.92%1.93M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -21.82%62.07M |
| Cash outflows from investing activities | -40.75%10.11M | -54.52%121.15M | -46.60%96.66M | -13.32%69.33M | -62.45%17.06M | -20.66%266.39M | -45.90%181.02M | -60.42%79.99M | -68.50%45.45M | -36.74%335.75M |
| Net cash flows from investing activities | -162.17%-5.72M | -100.14%-1.34M | -98.24%18.36M | -95.26%40.76M | -98.43%9.2M | 903.33%957.43M | 751.06%1.04B | 912.66%860.37M | 677.37%584.96M | 72.18%-119.18M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --3.64M | ---- | ---- | ---- | ---- | -67.88%26.48M | 19.34%26.48M | 13.53%25.19M | -43.96%10.3M | 207.11%82.43M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --3.64M | ---- | ---- | ---- | ---- | -67.88%26.48M | 19.34%26.48M | 13.53%25.19M | -43.96%10.3M | 207.11%82.43M |
| Cash from borrowing | 6.40%228M | -9.22%933.67M | -22.04%716.3M | -29.90%328.3M | -10.03%214.28M | -50.98%1.03B | -54.69%918.86M | -75.31%468.35M | -73.63%238.16M | 45.28%2.1B |
| Cash received relating to other financing activities | -43.33%115.89M | 55.76%1.16B | 58.66%721.5M | 97.42%588.5M | --204.5M | -24.49%741.85M | -50.73%454.76M | 62.36%298.09M | ---- | 4.19%982.48M |
| Cash inflows from financing activities | -17.02%347.52M | 16.27%2.09B | 2.69%1.44B | 15.81%916.8M | 68.55%418.78M | -43.19%1.8B | -52.91%1.4B | -62.35%791.63M | -73.07%248.46M | 31.03%3.16B |
| Borrowing repayment | 487.94%473M | -74.35%820.57M | -73.02%598.57M | -86.94%163.06M | -92.08%80.45M | 42.37%3.2B | 71.83%2.22B | -0.21%1.25B | 60.40%1.02B | 165.13%2.25B |
| Dividend interest payment | -7.92%14.99M | -19.03%62.17M | -16.08%47.71M | -29.21%32.22M | -31.90%16.28M | -44.47%76.78M | -47.76%56.85M | -28.88%45.52M | -0.09%23.91M | 4.48%138.26M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | --980K | --980K | --980K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | -66.98%78.58M | 562.34%1.34B | 50.94%889.31M | 74.36%684.27M | 3,271.33%238.02M | -48.50%202.39M | -42.36%589.17M | 16.29%392.44M | 107.65%7.06M | -39.03%393M |
| Cash outflows from financing activities | 69.25%566.58M | -36.07%2.22B | -46.39%1.54B | -47.86%879.56M | -68.01%334.75M | 25.19%3.48B | 18.27%2.86B | 2.05%1.69B | 58.45%1.05B | 71.02%2.78B |
| Net cash flows from financing activities | -360.68%-219.05M | 92.02%-134.13M | 93.32%-97.79M | 104.16%37.25M | 110.53%84.03M | -536.62%-1.68B | -365.72%-1.46B | -299.04%-895.33M | -404.50%-797.93M | -51.24%384.98M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -96.89%44.6K | 26.69%2.76M | -68.64%1.61M | -60.76%2.61M | 127.39%1.43M | -84.54%2.18M | -73.61%5.13M | -54.25%6.65M | 22.34%-5.23M | 1,345.40%14.1M |
| Net increase in cash and cash equivalents | -4,712.25%-68.15M | -14.20%-290.55M | -140.39%-240.28M | -161.78%-64.59M | 99.26%-1.42M | 61.41%-254.41M | 86.29%-99.95M | 121.58%104.54M | 70.10%-191.36M | -237.16%-659.23M |
| Add:Begin period cash and cash equivalents | -50.10%289.39M | -30.49%579.94M | -30.49%579.94M | -30.49%579.94M | -30.49%579.94M | -44.14%834.36M | -44.14%834.36M | -44.14%834.36M | -44.14%834.36M | 47.45%1.49B |
| End period cash equivalent | -61.76%221.24M | -50.10%289.39M | -53.75%339.66M | -45.11%515.36M | -10.03%578.53M | -30.49%579.94M | -3.97%734.4M | -6.95%938.9M | -24.67%643M | -44.14%834.36M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs